Stay updated on Ruxolitinib in COVID Cytokine Storm Clinical Trial

Sign up to get notified when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ruxolitinib in COVID Cytokine Storm Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The completed RUXCOVID clinical trial record is displayed, with details on the study design, eligibility, outcomes, locations, results, and documents, instead of a 403 error screen.
    Difference
    84%
    Check dated 2026-11-08T14:28:45.000Z thumbnail image
  3. Check
    15 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.8.0 instead of v3.7.2; the study page still shows a 403 error.
    Difference
    0.2%
    Check dated 2026-11-01T15:46:00.000Z thumbnail image
  4. Check
    22 days ago
    Change Detected
    Summary
    A sitewide NIH notice announces a terminology change from “Artificial Intelligence” to “Super Intelligence” and points visitors to updates and FAQs.
    Difference
    1%
    Check dated 2026-10-25T15:40:43.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The site footer now displays revision v3.7.2 instead of v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-18T15:39:03.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    The footer now identifies the ClinicalTrials.gov site revision as v3.7.1 instead of v3.7.0.
    Difference
    0.2%
    Check dated 2026-10-11T15:43:43.000Z thumbnail image
  7. Check
    57 days ago
    Change Detected
    Summary
    The study page now loads a 403 Forbidden error, replacing the study record content. Access to trial details, documents, and related information is no longer available on the page.
    Difference
    19%
    Check dated 2026-09-20T22:16:52.000Z thumbnail image

Stay in the know with updates to Ruxolitinib in COVID Cytokine Storm Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ruxolitinib in COVID Cytokine Storm Clinical Trial page.